What is NDC 60505-3645?

60505-3645 is the product NDC for Sitagliptin, Sitagliptin phosphate 100 mg/1 tablet, film coated, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sitagliptin?

14 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sitagliptin NDC 60505-3645 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-3645Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-3645Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-3645-3	6050536450360505364503	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-3)Marketed from May 28, 2026
60505-3645-9	6050536450960505364509	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60505-3645-9)Marketed from May 28, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sitagliptin
Generic name (nonproprietary): sitagliptin
Active ingredients: Sitagliptin phosphate — 100 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Apotex Corp.NDC labeler code 60505
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202425
Marketing start: May 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Dipeptidyl Peptidase 4 Inhibitors (Mechanism)
Identifiers: Product ID 60505-3645_70a9a9c7-ce7d-fdee-0b71-3db55d04f032SPL ID 70a9a9c7-ce7d-fdee-0b71-3db55d04f032
Pharmacologic class: Dipeptidyl Peptidase 4 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505364503 followed by a unit qualifier and the quantity

Package 60505-3645-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 60505-3645

What is NDC 60505-3645?: 60505-3645 is the product NDC for Sitagliptin, Sitagliptin phosphate 100 mg/1 tablet, film coated, listed with the FDA by Apotex Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sitagliptin.
What is the active ingredient?: Sitagliptin phosphate.
Who is the labeler?: Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sitagliptin?: 14 other product NDCs are listed under this name. See all Sitagliptin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sitagliptin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2607	00480-2607-5600480-2607-98
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2608	00480-2608-5600480-2608-98
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-2609	00480-2609-1000480-2609-5600480-2609-98
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3643	60505-3643-0360505-3643-09
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3644	60505-3644-0360505-3644-09
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-049	84677-0049-3084677-0049-90
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-050	84677-0050-90
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-051	84677-0051-3084677-0051-90
Sitagliptin	Sitagliptin 25 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1899	70710-1899-0370710-1899-09
Sitagliptin	Sitagliptin 50 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	70710-1900	70710-1900-0370710-1900-09

All 15 Sitagliptin NDCs

Other NDCs under ANDA 202425

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202425
Product	Strength	Form · route	Labeler	Product NDC
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3643
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Apotex Corp.	60505-3644
Sitagliptin	Sitagliptin phosphate 25 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-049
Sitagliptin	Sitagliptin phosphate 50 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-050
Sitagliptin	Sitagliptin phosphate 100 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	84677-051